:

Boosting research into post-infectious diseases – NAKO receives 27.8 million euros

The NAKO-PAIS project, funded by the Federal Ministry for Research, Technology and Space (BMFTR), aims to create a comprehensive database for researchers over the next two years. To this end, the health data from the German National Cohort (NAKO) will be supplemented with genetic, immunological and other molecular analyses. The aim is to expand the existing wealth of data from the German National Cohort (NAKO) so that it can be used for countless research projects on post-infectious diseases.

NAKO e.V. is receiving 27.8 million euros from the Federal Ministry of Research, Technology and Space (BMFTR) for the NAKO-PAIS project – an expansion of the NAKO database for research into post-infectious diseases. The project forms part of the National Decade against Post-Infectious Diseases. This ten-year initiative by the BMFTR has a total budget of 500 million euros and aims to investigate causes and disease mechanisms, as well as to develop new approaches to diagnosis and treatment. The aim is to improve care for those affected in the long term.

Gaining a better understanding of symptoms following infections

Post-acute infection syndromes (PAIS) encompass long-lasting health problems that may occur following an infection. These include Long COVID as well as other post-infectious conditions, such as myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). In this context, post-exertional malaise (PEM) – a marked worsening of existing symptoms following physical or mental exertion – is the main symptom of the ME/CFS condition.

The causes and biological mechanisms underlying these conditions are as yet poorly understood. NAKO-PAIS is now set to establish a comprehensive, long-term data resource that will enable researchers to investigate potential risk factors, disease mechanisms and the biological characteristics of resilience and recovery.

Long-term data and biological samples from NAKO

The project utilises data and biological samples from the NAKO, Germany’s largest population-based longitudinal study. More than 205,000 people across the country are taking part in the study. The research began in 2014; further surveys took place during and after the pandemic and are continuing as part of the ongoing 10-year follow-up. This enables the researchers to incorporate health data from the periods before, during and after the COVID-19 pandemic.

“The particular strength of the funded project lies in combining the extensive data from ten years of the NAKO study with PAIS-specific questionnaires, genetic data, antibody analyses and further molecular analyses. This unique combination of data enables researchers to identify risk factors for long-term symptoms caused by infections, to better understand different disease courses and to investigate the biological mechanisms underlying post-acute infection syndromes in a targeted manner,” reports Prof. Dr Annette Peters, Chair of the Board of Directors of NAKO e.V. and Director of the Institute of Epidemiology at Helmholtz Munich.

Extensive molecular analyses

NAKO-PAIS also complements clinical trials by providing a population-based perspective. It includes people without a diagnosis, those with mild disease progression, and control groups without long-term symptoms. This enables researchers to compare potential risk and protective factors, as well as different disease trajectories.

A key component of molecular analysis is genome sequencing, supplemented by so-called serolomics techniques. These analyse antibody patterns against various pathogens and can thus provide evidence of previous infections. This enables researchers to better investigate which symptoms are associated with specific pathogens and which biological characteristics play a role in various post-infectious conditions.

Prof. Dr Annette Peters at Helmholtz Munich is coordinating the project management and genetic analyses; Prof. Dr Berit Lange at the Helmholtz Centre for Infection Research (HZI) is coordinating the serolomics procedures; and Dr Harald Grallert at Helmholtz Munich is coordinating the molecular data. Also involved are the German Cancer Research Centre (DKFZ) in the field of serolomics (Dr Tim Waterboer) and for data storage and provision (Prof. Dr Oliver Stegle), and the University of Münster in the field of infectious disease epidemiology (Prof. Dr André Karch).

The molecular analyses carried out as part of NAKO-PAIS are based on existing participants in the German National Cohort (NAKO).These participants were randomly selected at the start of the study in 2014 via their regional registration office and invited to take part in the examinations by their designated study centre. It is therefore not possible for new participants to join the study at this stage.

More information

Press contact:

Dr. Friederike Fellenberg
NAKO Gesundheitsstudie
Head of Project and Science Communication
Am Taubenfeld 21/2
69123 Heidelberg
Germany
Phone.: +49 6221 42620-62
E-mail: friederike.fellenberg@nako.de

German National Cohort (NAKO)

The German National Cohort (NAKO Gesundheitsstudie) is the largest long-term population study in Germany. Since 2014, over 205,000 randomly selected people have been medically examined and asked about their lifestyle habits in 18 study centres. At the beginning of the study, the participants were aged between 20 and 69.

The German National Cohort (NAKO) is a prospective epidemiological cohort study. The researchers observe a large group, a so-called cohort, of healthy, ill or formerly ill people over a long period of time. The aim is to use scientific analyses of the participants’ data to investigate the frequency and causes of common diseases such as cancer, diabetes or cardiovascular diseases, to identify risk factors and to show ways of effective prevention and early detection.

The research project is supported by 26 organisations. Scientists from universities, the Helmholtz Association, the Leibniz Association and other research institutes in Germany are working together in a nationwide network. The study is being carried out by the NAKO e.V. association. It is financed by public funds from the Federal Ministry of Research, Technology and Space (BMFTR), the Helmholtz Association and the participating federal states.